1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > Molecular Diagnostics Market by Application , Oncology, Genetics, Microbiology), Technology , End User , Product - Forecast to 2020

The molecular diagnostics market is estimated to grow at a CAGR of 9.3% to reach USD 9,333.8 million by 2020.

In this report, the molecular diagnostics market is broadly segmented on the basis of technologies, applications, products & services, and end users. On the basis of technology, the market is segmented into PCR, INAAT, microarrays, hybridization, DNA sequencing and next-generation sequencing , and other technologies. Among these technologies, PCR is expected to command the largest share while microarrays is expected to grow at the highest rate.

The molecular diagnostics market, by application, is classified into infectious diseases, oncology, genetics, blood screening, microbiology, and others . The infectious diseases segment will account for the largest share of the global molecular diagnostics market in 2015, followed by the blood screening and oncology segments.

On the basis of products and services, the molecular diagnostics market is segmented into instruments, reagents, and services & software. The reagents segment is expected to account for the largest share and highest CAGR of the molecular diagnostics market in 2015.
Based on end users, the market is segmented into hospital & academic laboratories, reference laboratories, and others . As most diagnostic tests are carried out in-house, the hospital & academic laboratories segment is expected to dominate the market. On the other hand, newly launched, complex, and highly specialized tests are mostly offered only at a few large reference laboratories, owing to which the reference laboratories segment is expected to grow at the highest rate during the forecast period.

The major factors driving this market are high prevalence of infectious diseases and various types of cancer; increasing awareness and acceptance of personalized medicine and companion diagnostics; development of biomarkers; and advancements in molecular techniques, proteomics, and reformations in the reimbursement system. However, increased cost of molecular diagnostics tools, dearth of skilled labor to handle new and complex platforms, and the complex regulatory framework are the major factors restraining the growth of the molecular diagnostics market.

Major players operating in the molecular diagnostics market are Roche Diagnostics , QIAGEN N.V. , Hologic Inc. , Grifols , Abbott Laboratories , Siemens Healthcare , Becton, Dickinson and Company , Beckman Coulter Inc. , bioMérieux SA , and Cepheid Inc. .

Scope of the Report

This market study majorly covers the products and services, applications, technologies, and end users for arriving at the overall molecular diagnostics market size in the period from 2015 to 2020.
Years Considered for the Study



Market Segmentation

Molecular Diagnostics Market, by Products and Services
Instruments
Reagents
Services & Software

Molecular Diagnostics Market, by Technology
Polymerase Chain Reaction
Isothermal Nucleic Acid Amplification Technology
Hybridization [In Situ Hybridization & Fluorescent In Situ Hybridization ]
DNA Sequencing and Next-generation Sequencing
Microarrays
Others

Molecular Diagnostics Market, by Application
Infectious Diseases
Oncology
Genetics
Blood Screening
Microbiology
Others

Molecular Diagnostics Market, by End User
Reference Laboratories
Hospital Laboratories
Others
Molecular Diagnostics Market, by Region
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Rest of Europe
Asia
Japan
India
China
Rest of Asia
Rest of the World
Latin America
o Brazil
o Mexico
o Rest of Latin America
Pacific Countries
Middle East & Africa


Table Of Contents

Molecular Diagnostics Market by Application , Oncology, Genetics, Microbiology), Technology , End User , Product - Forecast to 2020
TABLE OF CONTENTS

1 INTRODUCTION 22
1.1 OBJECTIVES OF THE STUDY 22
1.2 MARKET DEFINITION 22
1.3 MARKETS SCOPE 23
1.3.1 MARKETS COVERED 23
1.3.2 YEARS CONSIDERED FOR THE STUDY 24
1.4 CURRENCY 25
1.5 STAKEHOLDERS 25
2 RESEARCH METHODOLOGY 26
2.1 MARKET SIZE ESTIMATION 27
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 29
2.2.1 KEY DATA FROM SECONDARY SOURCES 30
2.2.2 KEY DATA FROM PRIMARY SOURCES 30
2.2.2.1 Key Industry Insights 31
2.2.3 ASSUMPTIONS 31
3 EXECUTIVE SUMMARY 32
4 PREMIUM INSIGHTS 36
4.1 MOLECULAR DIAGNOSTICS MARKET 36
4.2 MOLECULAR DIAGNOSTICS MARKET,INFECTIOUS DISEASES 37
4.3 MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY AND APPLICATION 38
4.4 MOLECULAR DIAGNOSTICS MARKET, BY END USER 39
4.5 MOLECULAR DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 40
5 MARKET OVERVIEW 41
5.1 INTRODUCTION 42
5.2 MARKET DYNAMICS 42
5.2.1 DRIVERS 43
5.2.1.1 High prevalence rate of infectious diseases and various types of cancer 43
5.2.1.2 Increasing awareness and acceptance of personalized medicine and companion diagnostics 43
5.2.1.3 Development of biomarker identification and advancements in molecular techniques 43
5.2.1.4 Growth in proteomics and genomics research 44
5.2.1.5 Reforms in the reimbursement system in the U.S. 44

5.2.2 RESTRAINTS 45
5.2.2.1 Molecular diagnostic tools with new and complex platforms demand skilled labor and mandatory training 45
5.2.2.2 Complex regulatory framework to delay approvals of new molecular diagnostic tests 45
5.2.3 OPPORTUNITIES 46
5.2.3.1 Advances in genomics 46
5.2.3.2 Significant growth prospects in developing countries 46
5.2.4 CHALLENGE 46
5.2.4.1 Dearth of trained professionals limiting the appropriate use of new molecular diagnostic technologies 46
6 MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 48
6.1 INTRODUCTION 49
6.2 INFECTIOUS DISEASES 50
6.2.1 HEPATITIS B 54
6.2.2 HEPATITIS C 54
6.2.3 HUMAN IMMUNODEFICIENCY VIRUS 55
6.2.4 TUBERCULOSIS 56
6.2.5 CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE 57
6.2.6 HUMAN PAPILLOMAVIRUS 58
6.2.7 METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS 59
6.2.8 OTHERS 60
6.3 ONCOLOGY 60
6.3.1 PROSTATE CANCER 64
6.3.2 BREAST CANCER 65
6.3.3 COLORECTAL CANCER 65
6.3.4 OTHERS 66
6.4 GENETIC TESTS 66
6.5 BLOOD SCREENING 69
6.6 MICROBIOLOGY 71
6.7 OTHERS 74
7 MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 77
7.1 INTRODUCTION 78
7.2 POLYMERASE CHAIN REACTION 79
7.3 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY 82
7.4 MICROARRAYS 85
7.5 HYBRIDIZATION 88
7.6 DNA SEQUENCING AND NEXT-GENERATION SEQUENCING 90
7.7 OTHER TECHNOLOGIES 94

8 MOLECULAR DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 97
8.1 INTRODUCTION 98
8.2 REAGENTS 99
8.3 INSTRUMENTS 102
8.4 SOFTWARE and SERVICES 105
9 MOLECULAR DIAGNOSTICS MARKET, BY END USER 109
9.1 INTRODUCTION 110
9.2 HOSPITAL/ACADEMIC LABORATORIES 111
9.3 REFERENCE LABORATORIES 114
9.4 OTHER END USERS 118
10 MOLECULAR DIAGNOSTIC MARKET, BY REGION 122
10.1 INTRODUCTION 123
10.2 NORTH AMERICA 125
10.2.1 U.S. 129
10.2.2 CANADA 132
10.3 EUROPE 135
10.3.1 U.K. 137
10.3.2 GERMANY 139
10.3.3 FRANCE 141
10.3.4 ITALY 144
10.3.5 SPAIN 146
10.3.6 REST OF EUROPE 148
10.4 ASIA 150
10.4.1 JAPAN 153
10.4.2 INDIA 155
10.4.3 CHINA 158
10.4.4 REST OF ASIA 160
10.5 REST OF THE WORLD 162
10.5.1 LATIN AMERICA 165
10.5.1.1 Mexico 167
10.5.1.2 Brazil 169
10.5.1.3 Rest of Latin America 171
10.5.2 PACIFIC COUNTRIES 173
10.5.3 MIDDLE EAST and AFRICA 175

11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 MARKET SHARE ANALYSIS 179
11.3 MOLECULAR DIAGNOSTICS MARKET COMPETITOR SHARE ANALYSIS, BY APPLICATION 180
11.3.1 MARKET SHARE ANALYSIS FOR INFECTIOUS DISEASE DIAGNOSTICS APPLICATIONS 180
11.3.2 MARKET SHARE ANALYSIS FOR BLOOD SCREENING APPLICATIONS 181
11.3.3 MARKET SHARE ANALYSIS FOR MICROBIOLOGY APPLICATIONS 182
11.3.4 MARKET SHARE ANALYSIS FOR ONCOLOGY APPLICATIONS 183
11.3.5 MARKET SHARE ANALYSIS FOR GENETIC TESTING 185
11.4 MOLECULAR DIAGNOSTICS MARKET SHARE ANALYSIS, BY TECHNOLOGY 185
11.4.1 POLYMERASE CHAIN REACTION 185
11.4.2 DNA SEQUENCING AND NGS 186
11.4.3 MICROARRAY 187
11.4.4 HYBRIDIZATION 188
11.4.5 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY 189
11.5 PRODUCT APPROVALS 191
11.6 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS 192
11.7 NEW PRODUCT LAUNCHES 193
11.8 ACQUISITIONS 194
11.9 OTHER DEVELOPMENTS 195
12 COMPANY PROFILES 196
12.1 INTRODUCTION 196
12.2 ABBOTT LABORATORIES 197
12.3 QIAGEN N.V. 203
12.4 ROCHE DIAGNOSTICS 209
12.5 HOLOGIC, INC. 216
12.6 GRIFOLS 219
12.7 SIEMENS HEALTHCARE 222
12.8 BECTON, DICKINSON AND COMPANY 225
12.9 BECKMAN COULTER INC. 231
12.10 BIOMÉRIEUX SA 235
12.11 CEPHEID INC. 238
*Details On Financials, Products and Services, Key Strategy, and Recent Developments Might Not Be Captured In Case Of Unlisted Companies.

13 APPENDIX 242
13.1 INSIGHTS OF INDUSTRY EXPERTS 242
13.2 DISCUSSION GUIDE 242
13.3 OTHER DEVELOPMENTS 245
13.3.1 ABBOTT LABORATORIES 245
13.3.2 QIAGEN N.V. 247
13.3.3 ROCHE DIAGNOSTICS 249
13.3.4 HOLOGIC INC. 250
13.3.5 HOLOGIC INC. 250
13.3.6 SIEMENS HEALTHCARE 250
13.3.7 BECTON, DICKINSON AND COMPANY 251
13.3.8 BECTON, DICKINSON AND COMPANY 253
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 256
13.5 AVAILABLE CUSTOMIZATIONS 257
13.6 RELATED REPORTS 258

LIST OF TABLES

TABLE 1 HIGH PREVALENCE OF INFECTIOUS DISEASES and CANCER AND GROWTH IN GENOMICS RESEARCH TO DRIVE THE MOLECULAR DIAGNOSTICS MARKET 44
TABLE 2 REQUIREMENT OF HIGHLY SKILLED LABOR AND COMPLEX REGULATORY FRAMEWORK RESTRAINING MARKET GROWTH 45
TABLE 3 DEVELOPING COUNTRIES PROVIDE SIGNIFICANT GROWTH OPPORTUNITIES FOR THE MOLECULAR DIAGNOSTICS MARKET 46
TABLE 4 DEARTH OF TRAINED PROFESSIONALS IS LIMITING THE APPROPRIATE USE OF NEW MOLECULAR DIAGNOSTIC TECHNOLOGIES 47
TABLE 5 MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2015-2020 49
TABLE 6 INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REGION,
2015-2020 51
TABLE 7 NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE,
BY COUNTRY, 2015-2020 51
TABLE 8 EUROPE: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY,
2015-2020 51
TABLE 9 ASIA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY,
2015-2020 52
TABLE 10 ROW: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY,
2015-2020 52
TABLE 11 LATIN AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2015-2020 52
TABLE 12 INFECTIOUS DISEASES DIAGNOSTICS MARKET SIZE, BY THERAPEUTIC AREA, 2015-2020 53
TABLE 13 HEPATITIS B DIAGNOSTICS MARKET SIZE, BY REGION, 2015-2020 54
TABLE 14 HEPATITIS B DIAGNOSTICS MARKET SIZE, BY REGION, 2015-2020 54
TABLE 15 HEPATITIS C MARKET SIZE, BY REGION, 2015-2020 55
TABLE 16 HEPATITIS C MARKET SIZE, BY REGION, 2015-2020 55
TABLE 17 HIV DIAGNOSTICS MARKET SIZE, BY REGION, 2015-2020 55
TABLE 18 HEPATITIS C MARKET SIZE, BY REGION, 2015-2020 56
TABLE 19 TB DIAGNOSTICS MARKET SIZE, BY REGION, 2015-2020 56
TABLE 20 TB DIAGNOSTICS MARKET SIZE, BY REGION, 2015-2020 57
TABLE 21 CT/NG DIAGNOSTICS MARKET SIZE, BY REGION, 2015-2020 57
TABLE 22 CT/NG DIAGNOSTICS MARKET SIZE, BY REGION, 2015-2020 57
TABLE 23 HPV DIAGNOSTICS MARKET SIZE, BY REGION, 2015-2020 58
TABLE 24 HPV DIAGNOSTICS MARKET SIZE, BY REGION, 2015-2020 58
TABLE 25 MRSA DIAGNOSTICS MARKET SIZE, BY REGION, 2015-2020 59
TABLE 26 MRSA DIAGNOSTICS MARKET SIZE, BY REGION, 2015-2020 59
TABLE 27 OTHER INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REGION,
2015-2020 60
TABLE 28 ONCOLOGY DIAGNOSTICS MARKET SIZE, BY REGION, 2015-2020 61
TABLE 29 NORTH AMERICA: ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY,
2015-2020 61
TABLE 30 EUROPE: ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY,
2015-2020 62
TABLE 31 ASIA: ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY,
2015-2020 62
TABLE 32 ROW: ONCOLOGY MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY,
2015-2020 62
TABLE 33 LATIN AMERICA: ONCOLOGY MOLECULAR DIAGNOSTICS MARKET SIZE,
BY COUNTRY, 2015-2020 63
TABLE 34 ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2015-2020 63
TABLE 35 ONCOLOGY MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOMARKER,
2015-2020 63
TABLE 36 PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY REGION,
2015-2020 64
TABLE 37 BREAST CANCER DIAGNOSTICS MARKET SIZE, BY REGION,
2015-2020 65
TABLE 38 COLORECTAL CANCER DIAGNOSTICS MARKET SIZE, BY REGION,
2015-2020 65
TABLE 39 OTHER CANCER DIAGNOSTICS MARKET SIZE, BY REGION,
2015-2020 66
TABLE 40 GENETIC TESTS MARKET SIZE, BY REGION, 2015-2020 66
TABLE 41 NORTH AMERICA: GENETICS TESTS MARKET SIZE, BY COUNTRY,
2015-2020 67
TABLE 42 EUROPE: GENETIC TESTS MARKET SIZE, BY COUNTRY, 2015-2020 68
TABLE 43 ASIA: GENETIC TESTS MARKET SIZE, BY COUNTRY, 2015-2020 68
TABLE 44 ROW: GENETIC TESTS MARKET SIZE, BY COUNTRY, 2015-2020 68
TABLE 45 LATIN AMERICA: GENETIC TESTS MARKET SIZE, BY COUNTRY,
2015-2020 69
TABLE 46 BLOOD SCREENING MARKET SIZE, BY REGION, 2015-2020 69
TABLE 47 NORTH AMERICA: BLOOD SCREENING MARKET SIZE, BY COUNTRY,
2015-2020 70
TABLE 48 EUROPE: BLOOD SCREENING MARKET SIZE, BY COUNTRY,
2015-2020 70
TABLE 49 ASIA: BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2015-2020 70
TABLE 50 ROW: BLOOD SCREENING MARKET SIZE, BY COUNTRY,
2015-2020 71
TABLE 51 LATIN AMERICA: BLOOD SCREENING MARKET SIZE, BY COUNTRY,
2015-2020 71
TABLE 52 MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION,
2015-2020 72
TABLE 53 NORTH AMERICA: MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET SIZE,
BY COUNTRY, 2015-2020 72
TABLE 54 EUROPE: MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2015-2020 73
TABLE 55 ASIA: MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2015-2020 73
TABLE 56 ROW: MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2015-2020 73
TABLE 57 LATIN AMERICA: MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET SIZE,
BY COUNTRY, 2015-2020 74
TABLE 58 OTHER MOLECULAR DIAGNOSTICS APPLICATIONS MARKET SIZE, BY REGION, 2015-2020 74
TABLE 59 NORTH AMERICA: OTHER MOLECULAR DIAGNOSTICS APPLICATIONS MARKET SIZE, BY COUNTRY, 2015-2020 75
TABLE 60 EUROPE: OTHER MOLECULAR DIAGNOSTICS APPLICATIONS MARKET SIZE,
BY COUNTRY, 2015-2020 75
TABLE 61 ASIA: OTHER MOLECULAR DIAGNOSTICS APPLICATIONS MARKET SIZE,
BY COUNTRY, 2015-2020 76
TABLE 62 ROW: OTHER MOLECULAR DIAGNOSTICS APPLICATIONS MARKET SIZE,
BY COUNTRY, 2015-2020 76
TABLE 63 LATIN AMERICA: OTHER MOLECULAR DIAGNOSTICS APPLICATIONS MARKET SIZE, BY COUNTRY, 2015-2020 76
TABLE 64 MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2013-2020 78
TABLE 65 MOLECULAR DIAGNOSTICS MARKET SIZE FOR PCR, BY REGION,
2013-2020 80
TABLE 66 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR PCR,
BY COUNTRY, 2013-2020 80
TABLE 67 EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE FOR PCR, BY COUNTRY,
2013-2020 80
TABLE 68 ASIA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR PCR, BY COUNTRY,
2013-2020 81
TABLE 69 ROW: MOLECULAR DIAGNOSTICS MARKET SIZE FOR PCR, BY REGION,
2013-2020 81
TABLE 70 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR PCR, BY COUNTRY, 2013-2020 81
TABLE 71 MOLECULAR DIAGNOSTICS MARKET SIZE FOR INAAT, BY REGION,
2013-2020 83
TABLE 72 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR INAAT,
BY COUNTRY, 2013-2020 83
TABLE 73 EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE FOR INAAT, BY COUNTRY, 2013-2020 83
TABLE 74 ASIA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR INAAT, BY COUNTRY,
2013-2020 84
TABLE 75 ROW: MOLECULAR DIAGNOSTICS MARKET SIZE FOR INAAT, BY REGION,
2013-2020 84
TABLE 76 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR INAAT,
BY COUNTRY, 2013-2020 84
TABLE 77 MOLECULAR DIAGNOSTICS MARKET SIZE FOR MICROARRAYS, BY REGION,
2013-2020 86
TABLE 78 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR MICROARRAYS, BY COUNTRY, 2013-2020 86
TABLE 79 EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE FOR MICROARRAYS,
BY COUNTRY, 2013-2020 86
TABLE 80 ASIA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR MICROARRAYS, BY COUNTRY, 2013-2020 87
TABLE 81 ROW: MOLECULAR DIAGNOSTICS MARKET SIZE FOR MICROARRAYS, BY REGION, 2013-2020 87
TABLE 82 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR MICROARRAYS,
BY COUNTRY, 2013-2020 87
TABLE 83 MOLECULAR DIAGNOSTICS MARKET SIZE FOR HYBRIDIZATION, BY REGION, 2013-2020 88
TABLE 84 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HYBRIDIZATION, BY COUNTRY, 2013-2020 88
TABLE 85 EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HYBRIDIZATION,
BY COUNTRY, 2013-2020 89
TABLE 86 ASIA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HYBRIDIZATION, BY COUNTRY, 2013-2020 89
TABLE 87 ROW: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HYBRIDIZATION, BY REGION, 2013-2020 90
TABLE 88 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HYBRIDIZATION,
BY COUNTRY, 2013-2020 90
TABLE 89 MOLECULAR DIAGNOSTICS MARKET SIZE FOR DNA SEQUENCING AND NGS,
BY REGION, 2013-2020 91
TABLE 90 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR DNA SEQUENCING AND NGS, BY COUNTRY, 2013-2020 92
TABLE 91 EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE FOR DNA SEQUENCING AND NGS, BY COUNTRY, 2013-2020 92
TABLE 92 ASIA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR DNA SEQUENCING AND NGS, BY COUNTRY, 2013-2020 93
TABLE 93 ROW: MOLECULAR DIAGNOSTICS MARKET SIZE FOR DNA SEQUENCING AND NGS, BY REGION, 2013-2020 93
TABLE 94 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR DNA SEQUENCING AND NGS, BY COUNTRY, 2013-2020 93
TABLE 95 MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER TECHNOLOGIES, BY REGION, 2013-2020 94
TABLE 96 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER TECHNOLOGIES, BY COUNTRY, 2013-2020 95
TABLE 97 EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER TECHNOLOGIES, BY COUNTRY, 2013-2020 95
TABLE 98 ASIA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER TECHNOLOGIES,
BY COUNTRY, 2013-2020 95
TABLE 99 ROW: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER TECHNOLOGIES,
BY REGION, 2013-2020 96
TABLE 100 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER TECHNOLOGIES, BY COUNTRY, 2013-2020 96
TABLE 101 MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCTS and SERVICES,
2015-2020 98
TABLE 102 MOLECULAR DIAGNOSTIC REAGENTS MARKET SIZE, BY REGION,
2015-2020 99
TABLE 103 MOLECULAR DIAGNOSTIC REAGENTS MARKET SIZE, BY TECHNOLOGY,
2015-2020 100
TABLE 104 NORTH AMERICA: MOLECULAR DIAGNOSTIC REAGENTS MARKET SIZE,
BY COUNTRY, 2015-2020 100
TABLE 105 EUROPE: MOLECULAR DIAGNOSTIC REAGENTS MARKET SIZE, BY COUNTRY, 2015-2020 100
TABLE 106 ASIA: MOLECULAR DIAGNOSTIC REAGENTS MARKET SIZE, BY COUNTRY,
2015-2020 101
TABLE 107 ROW: MOLECULAR DIAGNOSTIC REAGENTS MARKET SIZE, BY REGION,
2015-2020 101
TABLE 108 LATIN AMERICA: MOLECULAR DIAGNOSTIC REAGENTS MARKET SIZE, BY COUNTRY, 2015-2020 101
TABLE 109 MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET SIZE, BY REGION,
2015-2020 103
TABLE 110 MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET SIZE, BY TECHNOLOGY,
2015-2020 103
TABLE 111 NORTH AMERICA: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET SIZE,
BY COUNTRY, 2015-2020 104
TABLE 112 EUROPE: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET SIZE, BY COUNTRY, 2015-2020 104
TABLE 113 ASIA: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET SIZE, BY COUNTRY, 2015-2020 104
TABLE 114 ROW: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET SIZE, BY REGION,
2015-2020 105
TABLE 115 LATIN AMERICA: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET SIZE,
BY COUNTRY, 2015-2020 105
TABLE 116 MOLECULAR DIAGNOSTIC SOFTWARE and SERVICES MARKET SIZE, BY REGION, 2015-2020 106
TABLE 117 NORTH AMERICA: MOLECULAR DIAGNOSTIC SOFTWARE and SERVICES MARKET SIZE, BY COUNTRY, 2015-2020 107
TABLE 118 EUROPE: MOLECULAR DIAGNOSTIC SOFTWARE and SERVICES MARKET SIZE,
BY COUNTRY, 2015-2020 107
TABLE 119 ASIA: MOLECULAR DIAGNOSTIC SOFTWARE and SERVICES MARKET SIZE,
BY COUNTRY, 2015-2020 107
TABLE 120 ROW: MOLECULAR DIAGNOSTIC SOFTWARE and SERVICES MARKET SIZE,
BY REGION, 2015-2020 108
TABLE 121 LATIN AMERICA: MOLECULAR DIAGNOSTIC SOFTWARE and SERVICES MARKET SIZE, BY COUNTRY, 2015-2020 108
TABLE 122 MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2013-2020 110
TABLE 123 MOLECULAR DIAGNOSTICS MARKET SIZE FOR HOSPITAL/ACADEMIC LABORATORIES, BY REGION, 2013-2020 111
TABLE 124 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HOSPITAL/ACADEMIC LABORATORIES, BY COUNTRY, 2013-2020 112
TABLE 125 EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HOSPITAL/ACADEMIC LABORATORIES, BY COUNTRY, 2013-2020 112
TABLE 126 ASIA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HOSPITAL/ACADEMIC LABORATORIES, BY COUNTRY, 2013-2020 113
TABLE 127 ROW: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HOSPITAL/ACADEMIC LABORATORIES, BY REGION, 2013-2020 113
TABLE 128 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HOSPITAL/ACADEMIC LABORATORIES, BY COUNTRY, 2013-2020 113
TABLE 129 MOLECULAR DIAGNOSTICS MARKET SIZE FOR REFERENCE LABORATORIES,
BY REGION, 2013-2020 115
TABLE 130 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR REFERENCE LABORATORIES, BY COUNTRY, 2013-2020 115
TABLE 131 EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE FOR REFERENCE LABORATORIES, BY COUNTRY, 2013-2020 116
TABLE 132 ASIA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR REFERENCE LABORATORIES, BY COUNTRY, 2013-2020 117
TABLE 133 ROW: MOLECULAR DIAGNOSTICS MARKET SIZE FOR REFERENCE LABORATORIES, BY REGION, 2013-2020 117
TABLE 134 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR REFERENCE LABORATORIES, BY COUNTRY, 2013-2020 117
TABLE 135 MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER END USERS, BY REGION, 2013-2020 119
TABLE 136 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2013-2020 119
TABLE 137 EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER END USERS,
BY COUNTRY, 2013-2020 119
TABLE 138 ASIA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER END USERS,
BY COUNTRY, 2013-2020 120
TABLE 139 ROW: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER END USERS,
BY REGION, 2013-2020 120
TABLE 140 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER END USERS LABORATORIES, BY COUNTRY, 2013-2020 121
TABLE 141 MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2013-2020 125
TABLE 142 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 127
TABLE 143 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2013-2020 128
TABLE 144 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT,
2013-2020 128
TABLE 145 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2013-2020 129
TABLE 146 U.S.: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2013-2020 130
TABLE 147 U.S.: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2013-2020 131
TABLE 148 U.S.: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT,
2013-2020 131
TABLE 149 U.S.: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2013-2020 132
TABLE 150 CANADA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2013-2020 133
TABLE 151 CANADA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2013-2020 133
TABLE 152 CANADA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT,
2013-2020 134
TABLE 153 CANADA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2013-2020 134
TABLE 154 EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2013-2020 135
TABLE 155 EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2013-2020 136
TABLE 156 EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT,
2013-2020 136
TABLE 157 EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2013-2020 137
TABLE 158 U.K.: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2013-2020 138
TABLE 159 U.K.: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2013-2020 138
TABLE 160 U.K.: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT,
2013-2020 139
TABLE 161 U.K.: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2013-2020 139
TABLE 162 GERMANY: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2013-2020 140
TABLE 163 GERMANY: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2013-2020 140
TABLE 164 GERMANY: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT,
2013-2020 141
TABLE 165 GERMANY: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2013-2020 141
TABLE 166 FRANCE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2013-2020 142
TABLE 167 FRANCE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2013-2020 142
TABLE 168 FRANCE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT,
2013-2020 143
TABLE 169 FRANCE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2013-2020 143
TABLE 170 ITALY: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2013-2020 144
TABLE 171 ITALY: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2013-2020 144
TABLE 172 ITALY: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT,
2013-2020 145
TABLE 173 ITALY: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2013-2020 145
TABLE 174 SPAIN: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2013-2020 146
TABLE 175 SPAIN: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2013-2020 146
TABLE 176 SPAIN: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT,
2013-2020 147
TABLE 177 SPAIN: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2013-2020 147
TABLE 178 ROE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2013-2020 148
TABLE 179 ROE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2013-2020 148
TABLE 180 ROE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT,
2013-2020 149
TABLE 181 ROE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2013-2020 149
TABLE 182 ASIA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2013-2020 151
TABLE 183 ASIA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2013-2020 151
TABLE 184 ASIA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT,
2013-2020 152
TABLE 185 ASIA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2013-2020 152
TABLE 186 JAPAN: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2013-2020 153
TABLE 187 JAPAN: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2013-2020 153
TABLE 188 JAPAN: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT,
2013-2020 154
TABLE 189 JAPAN: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2013-2020 154
TABLE 190 INDIA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2013-2020 156
TABLE 191 INDIA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2013-2020 156
TABLE 192 INDIA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT,
2013-2020 157
TABLE 193 INDIA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2013-2020 157
TABLE 194 CHINA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2013-2020 158
TABLE 195 CHINA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2013-2020 158
TABLE 196 CHINA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT,
2013-2020 159
TABLE 197 CHINA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2013-2020 159
TABLE 198 ROA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2013-2020 160
TABLE 199 ROA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2013-2020 160
TABLE 200 ROA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT,
2013-2020 161
TABLE 201 ROA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2013-2020 161
TABLE 202 ROW: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2013-2020 162
TABLE 203 ROW: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2013-2020 163
TABLE 204 ROW: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT,
2013-2020 164
TABLE 205 ROW: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2013-2020 164
TABLE 206 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 165
TABLE 207 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2013-2020 166
TABLE 208 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT,
2013-2020 166
TABLE 209 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2013-2020 167
TABLE 210 MEXICO: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2013-2020 167
TABLE 211 MEXICO: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2013-2020 168
TABLE 212 MEXICO: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT,
2013-2020 168
TABLE 213 MEXICO: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2013-2020 169
TABLE 214 BRAZIL: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2013-2020 169
TABLE 215 BRAZIL: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2013-2020 170
TABLE 216 BRAZIL: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT,
2013-2020 170
TABLE 217 BRAZIL: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2013-2020 171
TABLE 218 ROLA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2013-2020 171
TABLE 219 ROLA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2013-2020 172
TABLE 220 ROLA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT,
2013-2020 172
TABLE 221 ROLA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2013-2020 173
TABLE 222 PACIFIC COUNTRIES: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 173
TABLE 223 PACIFIC COUNTRIES: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2013-2020 174
TABLE 224 PACIFIC COUNTRIES: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2013-2020 174
TABLE 225 PACIFIC COUNTRIES: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2013-2020 175
TABLE 226 MIDDLE EAST and AFRICA: MOLECULAR DIAGNOSTICS MARKET SIZE,
BY TECHNOLOGY, 2013-2020 175
TABLE 227 MIDDLE EAST and AFRICA: MOLECULAR DIAGNOSTICS MARKET SIZE,
BY APPLICATION, 2013-2020 176
TABLE 228 MIDDLE EAST and AFRICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2013-2020 176
TABLE 229 MIDDLE EAST and AFRICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2013-2020 177
TABLE 230 PRODUCT APPROVALS, 2012-2015 191
TABLE 231 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2012-2015 192
TABLE 232 NEW PRODUCT LAUNCHES, 2012-2015 193
TABLE 233 ACQUISITIONS, 2012-2015 194
TABLE 234 OTHER DEVELOPMENTS, 2012-2015 195


LIST OF FIGURES


FIGURE 1 RESEARCH DESIGN 26
FIGURE 2 MARKET SIZE ESTIMATION AND DATA TRIANGULATION 28
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 28
FIGURE 4 MOLECULAR DIAGNOSTICS MARKET SNAPSHOT 32
FIGURE 5 REAGENTS TO ACCOUNT FOR THE LARGEST SHARE OF MOLECULAR DIAGNOSTICS MARKET DURING THE FORECAST PERIOD 33
FIGURE 6 HOSPITAL and ACADEMIC LABORATORIES TO LEAD THE MARKET DURING THE FORECAST PERIOD 33
FIGURE 7 INFECTIOUS DISEASES SEGMENT WILL CONTINUE TO DOMINATE THE MOLECULAR DIAGNOSTICS MARKET DURING THE FORECAST PERIOD 34
FIGURE 8 MICROARRAY SEGMENT POISED TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 35
FIGURE 9 PRODUCT APPROVALS IS THE DOMINANT STRATEGY AMONG MARKET PLAYERS 35
FIGURE 10 RISING PREVALENCE OF INFECTIOUS DISEASES and CANCER TO DRIVE MARKET GROWTH 36
FIGURE 11 MRSA WILL BE THE FASTEST-GROWING SEGMENT DURING THE FORECAST PERIOD 37
FIGURE 12 INFECTIOUS DISEASES SEGMENT DOMINATES THE MOLECULAR DIAGNOSTICS MARKET IN 2015 38
FIGURE 13 HOSPITAL and ACADEMIC LABORATORIES TO DOMINATE THE MOLECULAR DIAGNOSTICS MARKET BY 2020 39
FIGURE 14 REAGENTS SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 40
FIGURE 15 MOLECULAR DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND THREATS 42
FIGURE 16 INFECTIOUS DISEASE DIAGNOSTICS, THE LARGEST SEGMENT OF THE MARKET
IN 2015 50
FIGURE 17 MRSA DIAGNOSTICS HOLDS HIGHEST GROWTH POTENTIAL IN THE MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES DURING THE FORECAST PERIOD 53
FIGURE 18 NORTH AMERICA WILL CONTINUE TO LEAD IN ONCOLOGY MOLECULAR DIAGNOSTICS MARKET IN FORECAST PERIOD 61
FIGURE 19 EGFR ASSAY SEGMENT WILL GROW AT THE HIGHEST PACE DURING THE FORECAST PERIOD 64
FIGURE 20 NORTH AMERICA WILL CONTINUE TO DOMINATE GENETICS TESTS MARKET DURING THE FORECAST PERIOD 67
FIGURE 21 ASIA IS THE FASTEST-GROWING MARKET FOR OTHER APPLICATIONS 75
FIGURE 22 PCR TO DOMINATE THE MOLECULAR DIAGNOSTIC TECHNOLOGIES MARKET DURING THE FORECAST PERIOD 78
FIGURE 23 NORTH AMERICA TO DOMINATE THE PCR TECHNOLOGY MARKET DURING THE FORECAST PERIOD 79
FIGURE 24 ASIA TO GROW AT HIGHEST RATE FOR THE INAAT TECHNOLOGY MARKET DURING THE FORECAST PERIOD 82
FIGURE 25 NORTH AMERICA TO DOMINATE THE MICROARRAYS MARKET DURING THE FORECAST PERIOD 85
FIGURE 26 NORTH AMERICA TO DOMINATE THE DNA SEQUENCING AND NEXT-GENERATION SEQUENCING MARKET DURING THE FORECAST PERIOD 91
FIGURE 27 NORTH AMERICA TO DOMINATE THE OTHER TECHNOLOGIES MARKET DURING THE FORECAST PERIOD 94
FIGURE 28 REAGENTS TO FORM THE LARGEST SEGMENT OF THE MOLECULAR DIAGNOSTICS MARKET IN 2015 98
FIGURE 29 MOLECULAR DIAGNOSTIC REAGENTS MARKET IN ASIA TO GROW AT HIGHEST RATE IN 2015 99
FIGURE 30 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET IN 2015 102
FIGURE 31 MOLECULAR DIAGNOSTICS SOFTWARE and SERVICES MARKET IN ASIA TO GROW AT THE HIGHEST RATE 106
FIGURE 32 HOSPITAL/ACADEMIC LABORATORIES, THE MAJOR END USERS OF THE MOLECULAR DIAGNOSTICS MARKET 110
FIGURE 33 NORTH AMERICA TO CONTINUE TO DOMINATE THE HOSPITAL/ACADEMIC LABORATORIES MARKET DURING THE FORECAST PERIOD 111
FIGURE 34 ASIA: HIGHEST GROWTH POTENTIAL IN THE REFERENCE LABORATORIES END-USER MARKET SEGMENT 114
FIGURE 35 GERMANY IS THE LARGEST AND FASTEST-GROWING MARKET FOR REFERENCE LABORATORIES 116
FIGURE 36 NORTH AMERICA IS EXPECTED TO BE THE LARGEST REGIONAL SEGMENT IN THE MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS 118
FIGURE 37 ASIA-PACIFIC WILL BE THE FASTEST-GROWING REGION IN THE MOLECULAR DIAGNOSTICS MARKET 123
FIGURE 38 ASIAN MARKET FOR MOLECULAR DIAGNOSTICS PRODUCTS SHOWS SIGNIFICANT GROWTH OPPORTUNITIES 124
FIGURE 39 NORTH AMERICA WILL CONTINUE TO LEAD THE GLOBAL MOLECULAR DIAGNOSTICS MARKET IN THE FORECAST PERIOD 124
FIGURE 40 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET SNAPSHOT 126
FIGURE 41 PCR TECHNOLOGY SEGMENT WILL CONTINUE TO LEAD THE NORTH AMERICAN MARKET 127
FIGURE 42 MICROARRAY TECHNOLOGY SEGMENT IS GROWING AT THE FASTEST RATE DURING THE FORECAST PERIOD 130
FIGURE 43 REAGENT SEGMENT WILL CONTINUE TO DOMINATE MOLECULAR D

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 12800
  • Industry report
  • August 2016
  • by Venture Planning Group

This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test. This comprehensive five-country report identifies and ...

Europe Cancer Diagnostics Market Future Horizons and Growth Strategies: Supplier Shares by Tumor Marker, Country Segment Forecasts, Competitive Intelligence, Opportunities

Europe Cancer Diagnostics Market Future Horizons and Growth Strategies: Supplier Shares by Tumor Marker, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 12800
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $19,700.  DataPack (test volumes, sales forecasts, supplier shares) $12,800.VPGMarketResearch.com's new report is a strategic analysis of the major business opportunities emerging in the ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.